Herantis Pharma Oyj: Manager’s Transactions – James Phillips

Herantis Pharma Oyj: Manager’s Transactions – James Phillips

Herantis Pharma Plc
Company release 30 Aug 2018 at 9:00 am

Herantis Pharma Oyj – Managers’ Transactions

____________________________________________

Person subject to the notification requirement

Name: Phillips, James

Position: Member of the Board/Deputy member

Issuer: Herantis Pharma Oyj

LEI: 743700W4CQVYAT3WKK38

Notification type: INITIAL NOTIFICATION

Reference number: 743700W4CQVYAT3WKK38_20180828114932_2

____________________________________________

Transaction date: 2018-08-29

Venue not applicable

Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT

Instrument name: Optio-ohjelma 2014 I (Optio- ja muut erityiset oikeudet P003)

Nature of the transaction: ACCEPTANCE OF A STOCK OPTION

(X) Linked to stock option programme

Transaction details

(1): Volume: 6 Unit price:  0.00 EUR

Aggregated transactions

(1): Volume: 6 Volume weighted average price:  0.00 EUR

____________________________________________

Further information:

Herantis Pharma Plc, Pekka Simula, CEO, telephone: +358 40 7300 445
Company web site: www.herantis.com
Certified Advisor: UB Securities Ltd, telephone: +358 9 25 380 225

Distribution:

Nasdaq Helsinki
Main media
www.herantis.com